KemPharm Story

KMPHDelisted Stock  USD 5.81  0.02  0.34%   
Under 62% of KemPharm's investor base is looking to short. The analysis of current outlook of investing in KemPharm suggests that many traders are alarmed regarding KemPharm's prospects. KemPharm's investor sentiment overview provides quick insight into current market opportunities from investing in KemPharm. The current market sentiment, together with KemPharm's historical and current headlines, can help investors time the market. In addition, many technical investors use KemPharm stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
KemPharm stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of KemPharm daily returns and investor perception about the current price of KemPharm as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for KemPharm.

KemPharm Latest Timeline

KemPharm is listed for 5.81. About 18.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.69. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. KemPharm recorded a loss per share of 0.91. The entity last dividend was issued on the 28th of December 2020. The firm had 1:16 split on the 28th of December 2020.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in KemPharm Stock

If you are still planning to invest in KemPharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KemPharm's history and understand the potential risks before investing.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamental Analysis
View fundamental data based on most recent published financial statements
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets